4.7 Review

Current status of liposomal porphyrinoid photosensitizers

Journal

DRUG DISCOVERY TODAY
Volume 18, Issue 15-16, Pages 776-784

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2013.04.003

Keywords

-

Funding

  1. Polish Ministry of Science and Higher Education [N N401 067238]
  2. Department of Biomedical Sciences, Arthur A. Dugoni School of Dentistry, San Francisco, USA

Ask authors/readers for more resources

The complete eradication of various targets, such as infectious agents or cancer cells, while leaving healthy host cells untouched, is still a great challenge faced in the field of medicine. Photodynamic therapy (PDT) seems to be a promising approach for anticancer treatment, as well as to combat various dermatologic and ophthalmic diseases and microbial infections. The application of liposomes as delivery systems for porphyrinoids has helped overcome many drawbacks of conventional photosensitizers and facilitated the development of novel effective photosensitizers that can be encapsulated in liposomes. The development, preclinical studies and future directions for liposomal delivery of conventional and novel photosensitizers are reviewed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available